Key Takeaways Venafi featured in 9 of CYBR's top 10 Q1 deals, boosting cross-sell momentum across identity security. A Fortune 100 firm and PDS Health expanded with Venafi, each signing six-figure machine identity deals. CYBR says machine identities now outnumber human ones 80:1, up from 45:1, expanding its $60B TAM.CyberArk (CYBR) is gaining traction in the fast-growing machine identity market. CyberArk’s acquisition of Venafi, a leader in machine identity management, is emerging as a key growth catalyst ...